Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 9NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Sleep Wake Disorders 1Radiation Pneumonitis 1Radiation Fibrosis Syndrome 1Fatigue 1Depression 1Colorectal Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1Anxiety Disorders 1

Interventions

Cyclophosphamide 39Docetaxel 30Tamoxifen 29Paclitaxel 27Doxorubicin 26Trastuzumab 20Radiotherapy 18Epirubicin 16Letrozole 13exemestane 11Fluorouracil 11Anastrozole 11Capecitabine 10Bevacizumab 10Immunohistochemistry 9Filgrastim 9Fulvestrant 8Methotrexate 7Gene Expression Profiling 7palbociclib 6Zoledronic Acid 6Microarray Analysis 6Lapatinib 6Goserelin 6Chemotherapy, Adjuvant 6Amplified Fragment Length Polymorphism Analysis 6Vinorelbine 5Triptorelin Pamoate 5Carboplatin 5Absorptiometry, Photon 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Breast Neoplasms × Exercise Test × Clear all
NCT06069115 2025-02-11

RELIEF-COHORT

Meshalkin Research Institute of Pathology of Circulation

Recruiting
200 enrolled
Breast

Radiation Fibrosis Syndrome, Breast Neoplasms, Radiation Pneumonitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡